Original language | English (US) |
---|---|
Pages (from-to) | 77-86 |
Number of pages | 10 |
Journal | Neuromuscular Disorders |
Volume | 28 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2018 |
Keywords
- Biobank
- Biomarker
- Duchenne muscular dystrophy
- Dystrophin
- MRI
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Neurology
- Clinical Neurology
- Genetics(clinical)
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Neuromuscular Disorders, Vol. 28, No. 1, 01.01.2018, p. 77-86.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - 226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands
AU - workshop participants
AU - Aartsma-Rus, Annemieke
AU - Ferlini, Alessandra
AU - McNally, Elizabeth M.
AU - Spitali, Pietro
AU - Sweeney, H. Lee
AU - Szigyarto, Christina Al Khalili
AU - Bello, Luca
AU - Bronson, Abby
AU - Brown, Kristy
AU - Buccella, Filippo
AU - Chadwick, Jessica
AU - Frank, Diane
AU - Hoffman, Eric
AU - Larkindale, Jane
AU - McClorey, G.
AU - Munschauer, Rick
AU - Muntoni, Francesco
AU - Owens, Jane
AU - Schara, Ulrike
AU - Straub, Volker
AU - Tinsley, Jon
AU - Versnel, Jenny
AU - Vroom, Elizabeth
AU - Welch, Ellen
N1 - Funding Information: This Workshop was made possible thanks to the financial support of the European Neuromuscular Centre (ENMC) and ENMC main sponsors: Funding Information: The workshop was organized with the support of Parent Project Muscular Dystrophy (PPMD) and Marathon Pharmaceuticals, which provided travel support for participants from the US via an unrestricted grant to PPMD in addition to ENMC support. It was attended by representatives of academic institutions, industry working in the Duchenne muscular dystrophy field and patient representatives. Funding Information: Pietro Spitali presented on an effort that was initiated after the 204th ENMC workshop to make an inventory of serum and plasma samples available for biomarker validation studies. The work was sponsored by a small grant from Duchenne Parent Project Netherlands. Samples have been identified, some of which are linked to functional data and some of which are longitudinal. It is clear that more effort is needed to collect additional samples and functional data in a controlled way. Samples collected in placebo arms of clinical trials would be ideal to validate candidate biomarkers.
PY - 2018/1/1
Y1 - 2018/1/1
KW - Biobank
KW - Biomarker
KW - Duchenne muscular dystrophy
KW - Dystrophin
KW - MRI
UR - http://www.scopus.com/inward/record.url?scp=85035314174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035314174&partnerID=8YFLogxK
U2 - 10.1016/j.nmd.2017.10.002
DO - 10.1016/j.nmd.2017.10.002
M3 - Article
C2 - 29203356
AN - SCOPUS:85035314174
SN - 0960-8966
VL - 28
SP - 77
EP - 86
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
IS - 1
ER -